{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:36:41Z","timestamp":1782311801472,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clon.2025.103945","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:01:45Z","timestamp":1758769305000},"page":"103945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The BRAFV600E Mutation Enhances Age-Based Prognostic Stratification in Radioiodine-Treated Papillary Thyroid Cancer: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2621-7991","authenticated-orcid":false,"given":"J.","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1243-3116","authenticated-orcid":false,"given":"H.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4278-2475","authenticated-orcid":false,"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8333-0883","authenticated-orcid":false,"given":"X.","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2261-4246","authenticated-orcid":false,"given":"Y.Z.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2025.103945_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clon.2025.103945_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.103945_bib3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1210\/jc.2017-02725","article-title":"Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?","volume":"103","author":"Ylli","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clon.2025.103945_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/cen.14675","article-title":"Age increased the cancer-specific mortality risk of thyroid cancer with lung metastasis","volume":"96","author":"Huang","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clon.2025.103945_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejso.2018.07.055","article-title":"Thyroidectomy for thyroid cancer in the elderly: A meta-analysis","volume":"45","author":"Joseph","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clon.2025.103945_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/thy.2019.0688","article-title":"Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System","volume":"30","author":"Trimboli","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.103945_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.103945_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101715","article-title":"Pediatric thyroid cancer: Recent developments","volume":"37","author":"Cherella","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.clon.2025.103945_bib9","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1158\/0008-5472.CAN-21-0761","article-title":"Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma","volume":"81","author":"Stosic","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.clon.2025.103945_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clon.2025.103945_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9959649","article-title":"Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma","volume":"2022","author":"Wei","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clon.2025.103945_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12020-013-0139-0","article-title":"BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?","volume":"45","author":"Puxeddu","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.clon.2025.103945_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.21037\/gs.2016.09.09","article-title":"BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence","volume":"5","author":"Czarniecka","year":"2016","journal-title":"Gland Surg"},{"key":"10.1016\/j.clon.2025.103945_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12957-021-02326-y","article-title":"Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma","volume":"19","author":"Zhou","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.clon.2025.103945_bib15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1515\/jpem-2020-0174","article-title":"BRAF V600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation","volume":"33","author":"Chakraborty","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clon.2025.103945_bib16","doi-asserted-by":"crossref","first-page":"e1670","DOI":"10.1210\/clinem\/dgad343","article-title":"Differentiated Thyroid Cancers in Young Adults Versus Children: Clinical Characteristics and 10-year Follow-up Outcomes","volume":"108","author":"Satapathy","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clon.2025.103945_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.103945_bib18","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.3390\/cancers15225395","article-title":"BRAFV600E Positivity-Dependent Effect of Age on Papillary Thyroid Cancer Recurrence Risk","volume":"15","author":"Park","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clon.2025.103945_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4149\/neo_2017_120","article-title":"A different prognostic value of BRAFV600E mutation positivity in various age groups of patients with papillary thyroid cancer","volume":"64","author":"Takacsova","year":"2017","journal-title":"Neoplasma"},{"key":"10.1016\/j.clon.2025.103945_bib20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/thy.2016.0547","article-title":"Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation","volume":"27","author":"Lee","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.103945_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13000-019-0849-6","article-title":"Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China","volume":"14","author":"Huang","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.clon.2025.103945_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4274\/jcrpe.3873","article-title":"Clinicopathological Characteristics of Papillary Thyroid Cancer in Children with Emphasis on Pubertal Status and Association with BRAFV600E Mutation","volume":"9","author":"Poyrazo\u011flu","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.clon.2025.103945_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.2016.0339","article-title":"Single Point Mutations in Pediatric Differentiated Thyroid Cancer","volume":"27","author":"Alzahrani","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.103945_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1093526616689628","article-title":"Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid Carcinoma","volume":"20","author":"Hardee","year":"2017","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.clon.2025.103945_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cncy.22746","article-title":"Single BRAFV600E mutation is not associated with aggressive biological behavior in adolescent and pediatric papillary thyroid carcinoma","volume":"131","author":"Zhou","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.clon.2025.103945_bib26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3390\/diagnostics13061187","article-title":"The Prognostic Significance of BRAF Gene Analysis in Children and Adolescents with Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis","volume":"13","author":"Kotanidou","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.clon.2025.103945_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/thy.2017.0422","article-title":"A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence","volume":"28","author":"Jianyong","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.103945_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40618-024-02480-6","article-title":"Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism","volume":"48","author":"Piticchio","year":"2025","journal-title":"J Endocrinol Invest"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:02:46Z","timestamp":1763679766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655525002006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S0936655525002006"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.103945","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The BRAFV600E Mutation Enhances Age-Based Prognostic Stratification in Radioiodine-Treated Papillary Thyroid Cancer: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.103945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103945"}}